ATE93543T1 - Varicella-zoster-virus als lebende rekombinante vakzine. - Google Patents
Varicella-zoster-virus als lebende rekombinante vakzine.Info
- Publication number
- ATE93543T1 ATE93543T1 AT87305202T AT87305202T ATE93543T1 AT E93543 T1 ATE93543 T1 AT E93543T1 AT 87305202 T AT87305202 T AT 87305202T AT 87305202 T AT87305202 T AT 87305202T AT E93543 T1 ATE93543 T1 AT E93543T1
- Authority
- AT
- Austria
- Prior art keywords
- zoster virus
- virus
- varicella zoster
- recombinant vaccine
- live recombinant
- Prior art date
Links
- 241000701085 Human alphaherpesvirus 3 Species 0.000 title abstract 4
- 108010008038 Synthetic Vaccines Proteins 0.000 title 1
- 229940124551 recombinant vaccine Drugs 0.000 title 1
- 201000006082 Chickenpox Diseases 0.000 abstract 2
- 206010046980 Varicella Diseases 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 244000052637 human pathogen Species 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87695686A | 1986-06-20 | 1986-06-20 | |
| EP87305202A EP0251534B1 (de) | 1986-06-20 | 1987-06-12 | Varicella-Zoster-Virus als lebende rekombinante Vakzine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE93543T1 true ATE93543T1 (de) | 1993-09-15 |
Family
ID=25368939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87305202T ATE93543T1 (de) | 1986-06-20 | 1987-06-12 | Varicella-zoster-virus als lebende rekombinante vakzine. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0251534B1 (de) |
| JP (1) | JP2523132B2 (de) |
| KR (1) | KR960008674B1 (de) |
| AT (1) | ATE93543T1 (de) |
| AU (1) | AU601747B2 (de) |
| CA (1) | CA1337596C (de) |
| DE (1) | DE3787131T2 (de) |
| DK (1) | DK312687A (de) |
| ES (1) | ES2058116T3 (de) |
| IE (1) | IE60898B1 (de) |
| IL (1) | IL82851A (de) |
| NZ (1) | NZ220645A (de) |
| PT (1) | PT85108B (de) |
| ZA (1) | ZA874434B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3706233A1 (de) * | 1987-02-26 | 1988-09-08 | Behringwerke Ag | Immunogene fusionsproteine, die epstein-barr-virusproteine enthalten |
| EP0427788B1 (de) * | 1988-08-08 | 1995-11-22 | The Upjohn Company | Verfahren zur isolierung für thymidin-kinase der herpesvirus kodierenden dns |
| US5324664A (en) * | 1988-08-08 | 1994-06-28 | The Upjohn Company | Herpes virus thymidien kinase-encoding DNA |
| JP3026029B2 (ja) * | 1991-04-26 | 2000-03-27 | 財団法人阪大微生物病研究会 | 組換え水痘ウイルスとその作製法 |
| WO1994002596A1 (en) | 1992-07-17 | 1994-02-03 | Merck & Co., Inc. | Method for preventing zoster or alleviating varicella related post-herpetic neuralgia |
| CA2177060A1 (en) * | 1993-12-21 | 1995-06-29 | Philip J. Provost | Thermostable varicella zoster virus |
| FR2952825B1 (fr) | 2009-11-24 | 2012-05-25 | Goaster Jacqueline Le | Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5341202B2 (de) * | 1974-03-12 | 1978-11-01 | ||
| US4603112A (en) * | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| CA1282721C (en) * | 1984-06-04 | 1991-04-09 | Bernard Roizman | Herpes simplex virus as a vector |
| IL76751A (en) * | 1984-11-01 | 1991-04-15 | American Home Prod | Method and oral vaccines against infectious organisms using live,recombinant adenovirus for the production of antibodies |
-
1987
- 1987-06-10 NZ NZ220645A patent/NZ220645A/xx unknown
- 1987-06-11 IL IL8285187A patent/IL82851A/en not_active IP Right Cessation
- 1987-06-12 AT AT87305202T patent/ATE93543T1/de not_active IP Right Cessation
- 1987-06-12 ES ES87305202T patent/ES2058116T3/es not_active Expired - Lifetime
- 1987-06-12 DE DE87305202T patent/DE3787131T2/de not_active Expired - Fee Related
- 1987-06-12 EP EP87305202A patent/EP0251534B1/de not_active Expired - Lifetime
- 1987-06-16 CA CA000539785A patent/CA1337596C/en not_active Expired - Fee Related
- 1987-06-17 PT PT85108A patent/PT85108B/pt not_active IP Right Cessation
- 1987-06-19 IE IE163987A patent/IE60898B1/en not_active IP Right Cessation
- 1987-06-19 AU AU74492/87A patent/AU601747B2/en not_active Ceased
- 1987-06-19 KR KR1019870006210A patent/KR960008674B1/ko not_active Expired - Fee Related
- 1987-06-19 ZA ZA874434A patent/ZA874434B/xx unknown
- 1987-06-19 DK DK312687A patent/DK312687A/da not_active Application Discontinuation
- 1987-06-19 JP JP62151539A patent/JP2523132B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| PT85108B (pt) | 1990-03-08 |
| ZA874434B (en) | 1987-12-21 |
| JP2523132B2 (ja) | 1996-08-07 |
| CA1337596C (en) | 1995-11-21 |
| IE871639L (en) | 1987-12-20 |
| IL82851A (en) | 1995-01-24 |
| DK312687A (da) | 1988-03-10 |
| PT85108A (en) | 1987-07-01 |
| DE3787131T2 (de) | 1994-02-03 |
| EP0251534A1 (de) | 1988-01-07 |
| AU7449287A (en) | 1987-12-24 |
| JPS6312277A (ja) | 1988-01-19 |
| DK312687D0 (da) | 1987-06-19 |
| IE60898B1 (en) | 1994-08-24 |
| NZ220645A (en) | 1989-10-27 |
| KR880000579A (ko) | 1988-03-26 |
| DE3787131D1 (de) | 1993-09-30 |
| IL82851A0 (en) | 1987-12-20 |
| AU601747B2 (en) | 1990-09-20 |
| KR960008674B1 (ko) | 1996-06-28 |
| ES2058116T3 (es) | 1994-11-01 |
| EP0251534B1 (de) | 1993-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9106879A (pt) | Virus mutuante nao retroviral,uso do mesmo,vacina e processo de manufaturar umvirus mutante | |
| DE69737886D1 (de) | Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays | |
| ATE246244T1 (de) | Rekombinante cmv-neutralisierungsproteine | |
| DK672789D0 (da) | Nukleinsyresekvens samt rekombinant vaertscelle transformeret med samme | |
| DE3787131D1 (de) | Varicella-Zoster-Virus als lebende rekombinante Vakzine. | |
| ATE230798T1 (de) | Rekombinanter herpes simplex gb-gd-impfstoff | |
| ATE73495T1 (de) | Impfstoff gegen varicella-zoster-virus. | |
| PT848615E (pt) | Vacinas de fiv de multiplos subtipos | |
| NO20030524L (no) | Vaksine mot vertscelleassosiert herpesvirus | |
| ES8505253A1 (es) | Un procedimiento para preparar un organismo unicelular que tiene una secuencia de adn que codifica un plipeptid0 que tiene un determinante inmunorreactivo u antigeno de una glicoproteina de virus de herpes simplex. | |
| AU605155B2 (en) | A structural phosphoprotein (PP 15) of human cytomegalovirus, and the preparation and use thereof | |
| HUP9901005A2 (hu) | Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B | |
| EP0507179A3 (en) | Equine herpes viruses (ehv) containing foreign dna, process for their preparation and their use as vaccines | |
| ATE102650T1 (de) | Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung. | |
| ATE244308T1 (de) | Rekombitante, equine herpesviren | |
| ES2074965A1 (es) | Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. | |
| DK200701150A (da) | Rekombinant poxvirus og vaccine mod herpesvirus indeholdende dette | |
| RU93056615A (ru) | Вектор, способ получения вектора, способ получения лекарственного препарата, способ активизации иммунитета | |
| CA2621088A1 (en) | Genetically engineered fowlpox-based vaccine strain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |